New approach aims to protect hearts of people with type 1 diabetes
NCT ID NCT06609356
Summary
This early-phase study is investigating whether adding a medication that helps the body remove sugar (an SGLT2 inhibitor) to standard insulin therapy can improve heart and blood vessel health in adults with type 1 diabetes. The goal is to see if this approach, which lowers the amount of insulin needed, can improve how the body uses sugar and supports healthy blood vessel function. Researchers will compare results in people with type 1 diabetes to those with a milder genetic form of diabetes and healthy volunteers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.